These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Management of feto-maternal red cell allo-immunizations]. Bricca P; Guinchard E; Guitton Bliem C Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546 [TBL] [Abstract][Full Text] [Related]
6. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D]. Liu KL; Li BJ; Peng JY Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866 [No Abstract] [Full Text] [Related]
8. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease. Berlin G; Selbing A; Gottvall T Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753 [No Abstract] [Full Text] [Related]
9. Severe hemolytic disease of the newborn due to anti-c. Appelman Z; Lurie S; Juster A; Borenstein R Int J Gynaecol Obstet; 1990 Sep; 33(1):73-5. PubMed ID: 1974537 [TBL] [Abstract][Full Text] [Related]
10. Red-cell antibodies in pregnancy: evidence overturned. Clark DA Lancet; 1996 Feb; 347(9000):485-6. PubMed ID: 8596262 [No Abstract] [Full Text] [Related]
11. [Two cases of unusual allo-immunization caused by atypical antibodies]. Le Vaillant C; Jacopin-Bruneau L; Nowak C; Riteau AS Presse Med; 2015 Oct; 44(10):1078-82. PubMed ID: 26319768 [No Abstract] [Full Text] [Related]
12. [Immunologic conflict due to erythrocytic antigens (its prevention and treatment)]. Shalimova MA Feldsher Akush; 1988 Dec; 53(12):26-30. PubMed ID: 3148481 [No Abstract] [Full Text] [Related]
13. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn. Alie-Daran SJ; Dugoujon JM; Fournie A Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368 [No Abstract] [Full Text] [Related]
14. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)]. Spasova K; Vŭlcheva B Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168 [No Abstract] [Full Text] [Related]
15. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis]. Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424 [TBL] [Abstract][Full Text] [Related]
16. [Modern diagnosis and therapy of fetomaternal blood group incompatibility]. Vetter K; Favre Y Arch Gynecol Obstet; 1990; 247 Suppl():S25-35. PubMed ID: 2128174 [No Abstract] [Full Text] [Related]
17. Management of severe red cell immunization in pregnancy. Kanhai HH Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42 Suppl():S90-5. PubMed ID: 1809617 [No Abstract] [Full Text] [Related]
18. Advanced techniques for the treatment of severe isoimmunization. Vomund SL; Witter SE MCN Am J Matern Child Nurs; 1994; 19(1):18-23. PubMed ID: 8201857 [No Abstract] [Full Text] [Related]